Investor Relations
We seek to enhance shareholder value not only through exceptional business performance and practices, but also through responsible and effective communication with our shareholders.
Symbol
NASDAQ : ASBPPrice
$Volume
Change
Delayed up to 15 minutes
Latest News
Aspire Biopharma Holdings, Inc. Announces the Execution of Securities Purchase Agreement
Aspire Biopharma Holdings, Inc. Announces the Execution of Securities Purchase AgreementNEW YORK CITY, NY / ACCESS Newswire / February 20, 2025 / Aspire Biopharma, Inc. ("Aspire" or the "Company"), a developer of a multi-faceted patent-protected disruptive drug...
Latest Presentation
Stock Information
Email Alerts
Subscribe to Aspire’s Investor Relations Email Alerts to receive direct real-time updates on market data, financial reports, and SEC filings.